top of page


Our laboratory was first established on the main campus of the University of Montreal back in 2001. In September 2019, we moved to the new research center of the university-affiliated Sainte-Justine Hospital. The center has state of the art equipment and services that includes flow cytometry and imaging platforms, a level 3 laboratory and many shared instruments. It is also located nearly critical services such as sequencing and proteomics.

About Us
Our Research

Intracellular transport of herpes simplex virus type 1 (HSV-1) capsids


Herpes viruses are wide spread pathogens that afflict most humans and are associated with several benign conditions (e.g. cold sores, mononucleosis, varicella, etc) but also sexually transmitted diseases, the zona, potentially severe congenital conditions and even virus-induced blindness. Once infected, these viruses remain dormant in our body and can periodically reactivate.

A major objective of the laboratory has been to characterize the molecular interactions of herpes simplex virus type 1 (HSV-1) with its host cells. This virus, as all members of the herpes family, replicates its genome and incorporates it into newly assembled viral capsids in the nucleus. These voluminous particles then escape the nucleus by an unusual route, since too big to traverse the nuclear pores. This involves the budding of the capsids through the inner nuclear membrane, yielding enveloped short-lived perinuclear viral particles. These particles then fuse with the outer nuclear membrane to release naked capsids in the cytoplasm. Another critical step in the egress of the newly produced viral particles is their acquisition of a final and mature envelope from an intracellular compartment, from which it finally reaches the cell surface. While this replication life cycle is generally accepted, the molecular machinery driving these processes are poorly understood (see the HSV-1 replication model).  

To study the complex exit of herpesviruses, our lab employs a combination of classical cell biology, biochemistry and virology tools as well as innovative technologies such as mass spectrometry, flow virometry and in vitro assays to address HSV-1 viral egress.  This has enabled us to define the protein composition of mature and intermediates viral particles, reveal the incorporation of many cellular particles in those particles and characterize the functions of a number of these host proteins. This should pave the way to novel therapeutic treatments by targeting cellular proteins that are essential for these viruses.





Strong of our expertise in virology, we are currently putting together a new research program that probes innovative means to detect, purify and characterize coronaviruses.

Our Research

Contact Us


Our Address

Mailing address:

Centre de recherche du CHU Sainte-Justine

3175 Chemin Côte Sainte-Catherine

Montréal, Qc, Canada

H3T 1C5

Shipping address:

Centre de recherche du CHU Sainte-Justine

5750 Chemin Hudson

Montréal, Qc, Canada

H3S 2G5


+1 (514) 345-4931 Ext 5201

© 2022- Lippé Laboratory

bottom of page